Market closedNon-fractional

Savara/SVRA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Savara

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Ticker

SVRA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Langhorne, United States

Employees

37

Savara Metrics

BasicAdvanced
$712M
Market cap
-
P/E ratio
-$0.37
EPS
0.72
Beta
-
Dividend rate
$712M
0.72
14.902
14.729
21.848
21.968
-30.22%
-58.59%
4.92
5.4
-12.463
41.07%
-18.56%

What the Analysts think about Savara

Analyst Ratings

Majority rating from 7 analysts.
Buy

Savara Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$20M
26.88%
Profit margin
0.00%
NaN%

Savara Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 13.60%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.07
-$0.10
-$0.09
-$0.11
-
Expected
-$0.08
-$0.07
-$0.10
-$0.10
-$0.11
Surprise
-9.68%
38.89%
-13.18%
13.60%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Savara stock?

Savara (SVRA) has a market cap of $712M as of July 05, 2024.

What is the P/E ratio for Savara stock?

The price to earnings (P/E) ratio for Savara (SVRA) stock is 0 as of July 05, 2024.

Does Savara stock pay dividends?

No, Savara (SVRA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Savara dividend payment date?

Savara (SVRA) stock does not pay dividends to its shareholders.

What is the beta indicator for Savara?

Savara (SVRA) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Savara stock

Buy or sell Savara stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing